BBOT Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

BridgeBio Oncology Therapeutics Inc (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.399, suggesting BBOT is Strong Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 9.239, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 10.628, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it Sell.

Technical Analysis for BBOT

Technical Sentiment Analysis for BridgeBio Oncology Therapeutics Inc (BBOT) As of 2026-04-02, BridgeBio Oncology Therapeutics Inc (BBOT) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 1 indicators are flashing buy, while 11 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for BBOT stands at 41.725, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.399, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 39.03 and the Commodity Channel Index (CCI) at -56.128 further confirm a -0.14 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, BBOT is trading below its 60-day moving average of $10.628 and below its 200-day long-term moving average of $11.172. Key price levels to watch include the immediate resistance at $9.423 and strong support at $8.458. A break above $9.423 could signal a bull continuation, while falling below $8.458 may test the next Fibonacci floor at $8.001.

BridgeBio Oncology Therapeutics Inc (BBOT) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	7.493	8.001	8.458	8.966	9.423	9.931	10.388
Fibonacci	8.001	8.37	8.598	8.966	9.335	9.563	9.931

BridgeBio Oncology Therapeutics Inc (BBOT) Technical Indicators

2026-04-02

Name	Value
RSI_14	41.725
STOCHk_14_3_3	39.03
STOCHd_14_3_3	28.873
CCI_20	-56.128
AO_5_34	-0.782
MOM_10	-0.14
MACD_12_26_9	-0.399

BridgeBio Oncology Therapeutics Inc (BBOT) Relative Strength Index (RSI) is 41.725, creating a Neutral signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic Oscillator is 39.03, creating a Neutral signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Stochastic RSI is 28.873, creating a Neutral signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Commodity Channel Index (CCI) is -56.128, creating a Neutral signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Awesome Oscillator is -0.782, creating a Sell signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Momentum is -0.14, creating a Sell signal.

BridgeBio Oncology Therapeutics Inc (BBOT) MACD is -0.399, creating a Sell signal.

BridgeBio Oncology Therapeutics Inc (BBOT) Moving Average

2026-04-02

Period	Simple	Signal
MA_5	8.89	Buy
MA_10	8.914	Sell
MA_20	9.239	Sell
MA_60	10.628	Sell
MA_200	11.172	Sell
MA_250	11.172	Sell

BridgeBio Oncology Therapeutics Inc (BBOT) 5-Day simple moving average is 8.89, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Buy.

BridgeBio Oncology Therapeutics Inc (BBOT) 10-Day simple moving average is 8.914, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 20-Day simple moving average is 9.239, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 60-Day simple moving average is 10.628, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 200-Day simple moving average is 11.172, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Sell.

BridgeBio Oncology Therapeutics Inc (BBOT) 250-Day simple moving average is 11.172, while BridgeBio Oncology Therapeutics Inc (BBOT) share price is $8.91, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for BBOT?

The overall technical consensus for BridgeBio Oncology Therapeutics Inc (BBOT) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 0 buy signals and 6 sell signals.

What are the key support and resistance levels for BridgeBio Oncology Therapeutics Inc (BBOT) today?

Based on pivot point calculations, BridgeBio Oncology Therapeutics Inc (BBOT) has an immediate support level at 8.458 and a major resistance level at 9.423. Traders also monitor the pivot point at 8.966 to determine the intraday trend direction.

Is BridgeBio Oncology Therapeutics Inc (BBOT) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for BridgeBio Oncology Therapeutics Inc (BBOT) is currently 41.725. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for BridgeBio Oncology Therapeutics Inc (BBOT)?

BridgeBio Oncology Therapeutics Inc (BBOT) Moving Averages Convergence Divergence (MACD) indicator is -0.399, suggesting BBOT is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for BridgeBio Oncology Therapeutics Inc.

How is BridgeBio Oncology Therapeutics Inc (BBOT) performing relative to its 200-day moving average?

BridgeBio Oncology Therapeutics Inc (BBOT) is currently trading at $8.91, which is below its 200-day simple moving average of 11.172. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.